Activators identified for the treatment of patients with diabetes and insulin resistance

 Cells with elongated mitochondrial network in red. Image: David Sebastián, IRB Barcelona

Cells with elongated mitochondrial network in red. Image: David Sebastián, IRB Barcelona


La Vanguardia, La Razón, Correo Farmacéutico, Health Canal, among other national and international media, have published an article about the research led by Antonio Zorzano, from IRB Barcelona, and Fernando Albericio, from the University of Barcelona. This study reveals activators of mitochondrial protein Mitofusin 2 that may be valuable in the treatment of type 2 diabetes.

Link to La Vanguardia

Link to Correo Farmacéutico

Link to Health Canal